Eagle Claw Capital Managment, LLC Gilead Sciences, Inc. Transaction History
Eagle Claw Capital Managment, LLC
- $666 Million
- Q3 2025
A detailed history of Eagle Claw Capital Managment, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 8,590 shares of GILD stock, worth $1.07 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
8,590
Previous 8,590
-0.0%
Holding current value
$1.07 Million
Previous $952,000
0.11%
% of portfolio
0.14%
Previous 0.15%
Shares
31 transactions
Others Institutions Holding GILD
# of Institutions
2,396Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...